Kohjin Bio Co.,Ltd. (177A) AI Stock Analysis

• Market Cap: ¥6.54B
• Dividend Yield: 1.62%
• Average Volume (3M): 3.64K
• Price to Earnings (P/E): 24.5
• Beta (1Y): 0.82
• Revenue Growth: N/A
• EPS Growth: N/A
• Country: JP
• Employees: 159
• Sector: Healthcare
• Sector Strength: 45
• Industry: Biotechnology
• EPS (TTM): 15.18
• Shares Outstanding: 5,111,600
• 10 Day Avg. Volume: 4,170
• 30 Day Avg. Volume: 3,643
• PEG Ratio: 0.16
• Price to Book (P/B): 1.55
• Price to Sales (P/S): 1.72
• P/FCF Ratio: 318.77
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0
• EPS Forecast (FY): N/A
• Revenue Forecast (FY): ¥5.58B

• Rating: 67 Neutral
• Price Target: ¥1,344.00 ▼(-11.87% Downside)
• Action: Downgraded Date: 10/30/25
• Date: Action: Downgraded 10/30/25

Kohjin Bio Co., Ltd. shows strong financial performance with robust growth in revenue and profitability, supported by a stable balance sheet. However, the technical indicators suggest a bearish trend, which could pose short-term risks. The valuation is reasonable, with a moderate P/E ratio and dividend yield, making it attractive for long-term investors. The absence of recent earnings call insights or notable corporate events limits additional context.

Positive Factors

Balance Sheet Strength

High equity ratio and low leverage provide lasting capital stability and financial flexibility. A 13.75% ROE signals efficient use of shareholder capital, supporting sustained reinvestment or shareholder returns and improving resilience to industry or funding shocks over the medium term.

Negative Factors

Low Free Cash Flow Ratio

Despite healthy operating cash conversion, the very low FCF/net income ratio indicates limited discretionary cash after capex and working capital. Persistently low free cash flow constrains long-term investment, deleverages flexibility for buybacks/dividends, and raises funding sensitivity.

Kohjin Bio Co.,Ltd. Business Overview & Revenue Model

Company Description

Kohjin Bio Co., Ltd. manufactures and sells animal blood, sera, tissue culture media, agar media for microorganism tests, in-vitro diagnostic agents, and cosmetics. The company offers tissue culture mediums for virus and recombinant protein produc...

Read more

Kohjin Bio Co., Ltd. manufactures and sells animal blood, sera, tissue culture media, agar media for microorganism tests, in-vitro diagnostic agents, and cosmetics. The company offers tissue culture mediums for virus and recombinant protein produc...

How the Company Makes Money

null...

Kohjin Bio Co.,Ltd. Financial Statement Overview

Breakdown	TTM	Mar 2025	Mar 2025	Mar 2023	Mar 2022
Income Statement
Total Revenue	5.18B	5.21B	4.77B	4.74B	3.95B
Gross Profit	2.31B	2.37B	1.88B	2.45B	2.04B
EBITDA	1.26B	1.41B	958.10M	1.44B	1.14B
Net Income	714.00M	794.76M	384.00M	829.79M	587.67M
Balance Sheet
Total Assets	9.17B	9.12B	6.64B	6.20B	5.60B
Cash, Cash Equivalents and Short-Term Investments	3.10B	3.15B	1.73B	1.46B	1.73B
Total Debt	1.99B	2.39B	2.47B	2.10B	2.23B
Total Liabilities	3.46B	3.34B	3.30B	3.18B	3.38B
Stockholders Equity	5.71B	5.78B	3.34B	3.02B	2.22B
Cash Flow
Free Cash Flow	0.00	28.05M	260.88M	-99.57M	559.44M
Operating Cash Flow	0.00	915.55M	823.68M	461.15M	762.98M
Investing Cash Flow	0.00	-1.09B	-577.35M	-575.46M	82.78M
Financing Cash Flow	0.00	1.38B	-1.35M	-172.21M	-360.17M

Kohjin Bio Co.,Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1525.00
• 50DMA: Positive
• 100DMA: Negative
• 200DMA: Negative
• MACD: Negative
• RSI: Neutral
• STOCH: Negative

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:177A, the sentiment is Positive. The current price of 1525 is above the 20-day moving average (MA) of 1206.17, above the 50-day MA of 1211.77, and above the 200-day MA of 1488.56, indicating a neutral trend. The MACD of 4.67 indicates Negative momentum. The RSI at 62.13 is Neutral, neither overbought nor oversold. The STOCH value of 89.35 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:177A.

Kohjin Bio Co.,Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
177A	67 Neutral	¥6.54B	24.52	―	1.62%	―	―
4978	56 Neutral	¥17.03B	120.78	―	―	1.24%	-33.41%
4974	52 Neutral	¥137.39B	-8.84	―	2.18%	-0.16%	-802.20%
Sector *	51 Neutral	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
7774	51 Neutral	¥24.20B	-34.16	―	―	-5.65%	-469.19%
7776	49 Neutral	¥11.31B	-8.14	―	―	-42.49%	-2.37%
4599	45 Neutral	¥19.06B	-11.30	―	―	―	11.34%